Life Sciences

In her sensationally titled report, “Killer Profits: How Big Pharma Takeovers Destroy Innovation and Harm Patients,” the deputy chair of the Congressional Progressive Caucus issued an ideologically inspired jeremiad grounded in assertions that are easily refuted with data.
Life Sciences
Check a box to narrow search for individual content items that cover numerous issues.
June 16, 2021
ITIF hosted an in-depth discussion with members of the Biden Administration about the report, implications for policy, and potential next steps.
May 20, 2021
In her sensationally titled report, “Killer Profits: How Big Pharma Takeovers Destroy Innovation and Harm Patients,” the deputy chair of the Congressional Progressive Caucus issued an ideologically inspired jeremiad grounded in assertions that are easily refuted with data.
May 10, 2021
Those who really want to solve the problem should abandon ill-advised proposals like patent waivers and focus instead on cooperative solutions to overcoming supply-chain constraints. The sooner that happens, the sooner we can all breathe freely again.
April 29, 2021
ITIF hosted an expert panel discussion about the report and the vital role IP has played throughout the pandemic.
April 29, 2021
From vaccines and therapeutics to delivery robots, intellectual property has played an indispensable role in facilitating development of a range of inventive products that have helped address health care, work, and social challenges brought on by the pandemic.
April 21, 2021
ITIF hosted an expert panel discussion exploring the groundbreaking innovations and policy considerations impacting the field of multi-cancer early detection.
April 20, 2021
ITIF hosted an expert panel discussion to explore the economic, health, and social effects that may persist post-COVID.
April 19, 2021
Blood-based multi-cancer early detection (MCED) technologies hold the promise to revolutionize America’s cancer-screening paradigm, dramatically expanding the range of detectable cancers and identifying them at earlier stages when cancers are more treatable. Policymakers should provide a supportive regulatory and coverage environment.
April 9, 2021
The United States and other developed, democratic societies have a moral obligation to ensure the world’s citizens receive COVID-19 vaccines and therapeutics. But there is absolutely no need to abrogate IP rights to fulfill that objective.
April 2, 2021
Intellectual property has proved to be indispensable in developing effective vaccines and therapeutics. Nevertheless, advocates have seized the moment to petition the WTO’s TRIPS Council not just to suspend patents, but also to reform national copyright laws governing digital access to knowledge, and data and text mining.

Pages